Reactivation and lytic replication of KSHV

Human Herpesviruses: Biology, Therapy, and Immunoprophylaxis

Volumn , Issue , 2007, Pages 434-460

  Lukac, David M ^a   Yuan, Yan ^b  

^a RUTGERS NEW JERSEY MEDICAL SCHOOL   (United States)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84929267586     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1017/CBO9780511545313.027     Document Type: Chapter

References (273)

1. Akula, S. M., Pramod, N. P., Wang, F. Z., and Chandran, B. (2001). Human herpesvirus 8 envelope-associated glycoprotein B interacts with heparan sulfate-like moieties. Virology, 284(2), 235-249.
2. Aluigi, M. G., Albini, A., Carlone, S. et al. (1996). KSHV sequences in biopsies and cultured spindle cells of epidemic, iatrogenic and Mediterranean forms of Kaposi's sarcoma. Res. Virol., 147(5), 267-275.
3. Ambroziak, J., Blackbourn, D., Herndier, B. et al. (1995). Herpesvirus-like sequenes in HIV-infected and uninfected Kaposi's sarcoma patients. Science, 268, 582-583.
4. Andreoni, M., Goletti, D., Pezzotti, P. et al. (2001). Prevalence, inci-dence and correlates of HHV-8/KSHV infection and Kaposi's sarcoma in renal and liver transplant recipients. J. Infect., 43(3), 195-199.
5. Asahara, T., Murohara, T., Sullivan, A. et al. (1997). Isolation of putative progenitor endothelial cells for angiogenesis. Science, 275(5302), 964-967.
6. AuCoin, D. P., Colletti, K. S., Xu, Y. et al. (2002). Kaposi's sarcoma-associated herpesvirus (human herpesvirus 8) contains two functional lytic origins of DNA replication. J. Virol., 76(15), 7890-7896.
7. AuCoin, D. P., Colletti, K. S., Cei, S. A., Papouskova, I., Tarrant, M., and Pari, G. S. (2004). Ampli?cation of the Kaposi's sarcoma-associated herpesvirus/human herpesvirus 8 lytic origin of DNA replication is dependent upona cis-acting AT-rich region and an ORF50 response element and the trans-acting factors ORF50 (K-Rta) and K8 (K-bZIP). Virology, 318, 542-555.
8. Baghian, A., Luftig, M., Black, J. B. et al. (2000). Glycoprotein B of human herpesvirus 8 is a component of the virion ina cleaved form composed of amino-and carboxyl-terminal fragments. Virology, 269(1), 18-25.
9. Barozzi, P., Luppi, M., Facchetti, F. et al. (2003). Post-transplant Kaposi sarcoma originates from the seeding of donor-derived progenitors. Nat. Med., 9(5), 554-561.
10. Bechtel, J., Grundhoff, A., and Ganem, D. (2005). RNAs in the virion of Kaposi's sarcoma-associated herpesvirus. J. Virol., 79(16), 10138-10146.
11. Beyari, M. M., Hodgson, T. A., Cook, R. D. et al. (2003). Multiple human herpesvirus-8 infection. J. Infect. Dis., 188(5), 678-689.
12. Biggar, R. J., Engels, E. A., Whitby, D. Kedes, D. H., and Goederr, J. J. (2003). Antibody reactivity to latent and lytic antigens to human herpesvirus-8 in longitudinally followed homosexual men. J. Infect. Dis., 187(1), 12-18.
13. Bigoni, B., Dolcetti, R., de Lellis, L. et al. (1996). Human Herpesvirus 8 is present in the lymphoid system of healthy persons and can reactivate in the course of AIDS. J. Infect. Dis., 173, 542-549.
14. Birkmann, A., Mahr, K., Ensser, A. et al. (2001). Cell surface heparan sulfate is a receptor for human herpesvirus 8 and interacts with envelope glycoprotein K8.1. J. Virol., 75(23), 11583-11593.
15. Blackbourn, D. J., Ambroziak, J., Lennette, E., Adams, M., Ramachandran, B., and Levy, J. A. (1997). Infectious human herpesvirus 8 in a healthy North American blood donor [see comments]. Lancet, 349(9052), 609-611.
16. Blackbourn, D. J., Lennette, E. T., Ambroziak, J., Mourich, D. V., and Levy, J. A. (1998). Human herpesvirus 8 detection in nasal secretions and saliva. J. Infect. Dis., 177(1), 213-216.
17. Blackbourn, D., Fujimura, S., Kutzkey, T., and Levy, J. (2000). Induc-tion of human herpesvirus-8 gene expression by recombinant interferon gamma. AIDS, 14, 98-99.
18. Blasig, C., Zietz, C., Haar, B. et al. (1997). Monocytes in Kaposi's sar-coma lesions are productively infected by human herpesvirus 8. J. Virol., 71, 7963-7968.
19. Boehmer, P. E. and Lehman, I. R. (1997). Herpes simplex virus DNA replication. Annu. Rev. Biochem., 66, 347-384.
20. Boneschi, V., Brambilla, L., Berti, E. etal. (2001). Human herpesvirus 8 DNA in the skin and blood of patients with Mediterranean Kaposi's sarcoma: Clinical correlations. Dermatology, 203(1), 19-23.
21. Boshoff, C., Schulz, T. F., Kennedy, M. M. et al. (1995). Kaposi's sarcoma-associated herpesvirus infects endothelial and spin-dle cells. Nat. Med., 1(12), 1274-1278.
22. Boshoff, C., Gao, S.-J., Healy, L. et al. (1998). Establishing a KSHV+ cell line (BCP-1) from peripheral blood and characterizing its growth in Nod/SCID mice. Blood, 91, 1671-1679.
23. Bourboulia, D., Aldam, D., Lagos, D. et al. (2004). Short-and long-term effects of highly active antiretroviral therapy on Kaposi sarcoma-associated herpesvirus immune responses and viraemia. AIDS, 18(3), 485-493.
24. Brenner, B., Weissmann-Brenner, A., Rakowsky, E. et al. (2002). Classical Kaposi sarcoma. Cancer, 95(9), 1982-1987.
25. Brown, H. J., Song, M. J., Deng, H., Wu, T. T., Cheng, G., and Sun, R. (2003). NF-kappaB inhibits gammaherpesvirus lytic repli-cation. J. Virol., 77(15), 8532-8540.
26. Browning, P., Sechler, J., Kaplan, M. et al. (1994). Identification and culture of Kaposi's sarcoma-like spindle cells from the periph-eral blood of human immunode?ciency virus-1-infected indi-viduals and normal controls. Blood, 84, 2711-2720.
27. Burysek, L., Yeow, W. S., Lubyova, B. et al.(1999). Functional analysis of human herpesvirus 8-encoded viral interferon regulatory factor 1 and its association with cellular interferon regulatory factors and p300. J. Virol., 73, 7334-7342.
28. Cai, J., Gill, P. S., Masood, R. et al. (1994). Oncostatin-M is an autocrine growth factor in Kaposi's sarcoma. Am. J. Pathol., 145(1), 74-79.
29. Campbell, T. B., Borok, M., Gwanzura, L. et al. (2000). Relation-ship of human herpesvirus 8 peripheral blood virus load and Kaposi's sarcoma clinical stage. AIDS, 14(14), 2109-2116.
30. Cannon, M. J., Dollard, S. C., Smith, D. K. et al. (2001). Blood-borne and sexual transmission of human herpesvirus 8 in women with or at risk for human immunode?ciency virus infection. N. Engl. J. Med., 344(9), 637-643.
31. Cannon, M. J., Dollard, S. C., Black, J. B. et al. (2003). Risk factors for Kaposi's sarcoma in men seropositive for both human her-pesvirus 8 and human immunode?ciency virus. AIDS, 17(2), 215-222.
32. Cannon, M., Cesarman, E., and Boshoff, C. (2006). KSHVG protein-coupled receptor inhibits lytic gene transcription in primary-effusion lymphoma cells via p21-mediated inhibition of Cdk2. Blood, 107(1), 277-284.
33. Carbone, A., Gloghini, A., Cozzi, M. R. et al. (2000). Expression of MUM1/IRF4 selectively clusters with primary effusion lym-phoma among lymphomatous effusions: Implications for dis-ease histogenesis and pathogenesis. Br. J. Haematol., 111(1), 247-257.
34. Carbone, A., Gloghini, A., Larocca, L. et al. (2001). Expression pro-?le of MUM1/IRF4, BCL-6, and CD138/syndecan-1 de?nes novel histogenetic subsets of human immunode?ciency virus-related lymphomas. Blood, 97, 744-751.
35. Cardin, R. D., Brooks, J. W., Sarawar, S. R., and Doherty, P. C. (1996). Progressive loss of CD8+ T cell-mediated control of a gamma-herpesvirus in the absence of CD4+ T cells. J. Exp. Med., 184(3), 863-871.
36. Carroll, K. D., Bu, W., Palmeri, D. et al. (2006). The KSHV lytic switch protein stimulates DNA binding of RBP-Jk/CSL to activate the notch pathway. J. Virol., 80(19).
37. Casper, C., Nichols, W. G., Huang, M. L., Corey, L., and Wald, A. (2004). Remission of HHV-8 and HIV-associated multicentric Castleman disease with ganciclovir treatment. Blood, 103(5), 1632-1634.
38. Casper, C., Redman, M., Huang, M. L. et al. (2004b). HIV infection and human herpesvirus-8 oral shedding among men who have sex with men. J. Acquir. Immune De?c. Syndr., 35(3), 233-238.
39. Cattani, P., Capuano, M., Cerimele, F. et al. (2001). Kaposi's sarcoma associatedwith previoushuman herpesvirus 8infectionin kid-ney transplant recipients. J. Clin. Microbiol., 39(2), 506-508.
40. Cattani, P., Capuano, M., Cerimele, F. et al. (1999). Human her-pesvirus 8 seroprevalence and evaluation of nonsexual trans-mission routes by detection of DNA in clinical specimens from human immunode?ciency virus-seronegative patients from central and southern Italy, with and without Kaposi's sarcoma. J. Clin. Microbiol., 37(4), 1150-1153.
41. Cattelan, A., Calabro, M., Gasperini, P. et al. (2001). Acquired immunode?ciency syndrome-related kaposi's sarcoma regression after highly active antiretroviral therapy: Biologic correlates of clinical outcome. J. Natl Cancer Inst. Monogr., 28, 44-49.
42. Cerimele, D., Cottoni, F., and Masala, M. V. (2000). Long latency of human herpesvirus type 8 infection and the appearance of classic Kaposi's sarcoma. J. Am. Acad. Dermatol., 43(4), 731-732.
43. Cesarman, E., Chang, Y., Moore, P. S., Said, J. W., and Knowles, D. M. (1995). Kaposi's sarcoma-associated herpesvirus-like DNA sequences in AIDS-related body-cavity-based lym-phomas. N. Engl. J. Med., 332(18), 1186-1191.
44. Cesarman, E., Nador, R. G., Aozasa, K., Delsol, G., Said, J. W., and Knowles, D. M. (1996). Kaposi's sarcoma-associated her-pesvirus in non-AIDS related lymphomas occurring in body cavities. Am. J. Pathol., 149(1), 53-57.
45. Challberg, M. D. and Kelly, T.J.(1989). Animalvirus DNAreplication. Annu. Rev. Biochem., 58, 671-717.
46. Chang, J., Renne, R., Dittmer, D., and Ganem, D. (2000). In?am-matory cytokines and the reactivation of Kaposi's sarcoma-associated herpesvirus lytic replication. Virology, 266, 17-25.
47. Chang, P. J., Shedd, D., Gradoville, L. et al. (2002). Open reading frame 50 protein of Kaposi's sarcoma-associated herpesvirus directly activates the viral PAN and K12 genes by binding to related response elements. J. Virol., 76(7), 3168-3178.
48. Chang, Y., Cesarman, E., Pessin, M. S. et al. (1994). Identification of herpesvirus-like DNA sequences in AIDS-associated Kaposi's sarcoma [see comments]. Science, 266(5192), 1865-1869.
49. Chang, H., Dittmer, D. P., Chul, S.-Y., Hong, Y., and Jung, J. U. (2005a). Role of notch signal transduction in Kaposi's sarcoma-associated herpesvirus gene Expression. J. Virol., 79(22), 14371-14382.
50. Chang, P.-J., Shedd, D., and Miller, G. (2005b). Two subclasses of Kaposi's sarcoma-associated herpesvirus lytic cycle promoters distinguished by open reading frame 50 mutant proteins that are de?cient in binding to DNA.
51. Chen, J., Ueda, K., Sakakibara, S. et al. (2001). Activation of latent Kaposi's sarcoma-associated herpesvirus by demethylation of the promoter of the lytic transactivator. Proc. Natl Acad. Sci. USA, 98(7), 4119-4124.
52. Chen, X., Lin, K., and Ricciardi, R. P. (2004). Human Kaposi's sar-coma herpesvirus processivity factor-8 functions as a dimer in DNA synthesis. J. Biol. Chem., 279(27), 28375-28386.
53. Cheng, E. H., Nicholas, J., Bellows, D. S. et al. (1997). A Bcl-2 homolog encoded by Kaposi sarcoma-associated virus, human herpesvirus 8, inhibits apoptosis but does not heterodimerize with Bax or Bak. Proc. Natl Acad. Sci. USA, 94(2), 690-694.
54. Ciufo, D. M., Cannon, J. S., Poole, L. J. et al. (2001). Spindle cell con-version by Kaposi's sarcoma-associated herpesvirus: Forma-tion of colonies and plaques with mixed lytic and latent gene expressionininfectedprimarydermalmicrovascular endothe-lial cell cultures. J. Virol., 75(12), 5614-5626.
55. Dal Canto, A., Virgin, H. I., and Speck, S. (2002). Ongoing viral repli-cation is required for gammaherpesvirus 68-induced vascular damage. J. Virol., 74, 11035-11310.
56. Davis, D. A., Rinderknecht, A. S., Zoeteweij, J. P. et al. (2001). Hypoxia induces lytic replication of Kaposi sarcoma-associated her-pesvirus. Blood, 97(10), 3244-3250.
57. Deng, H., Song, M. J., Chu, J. T., and Sun, R. (2002). Transcriptional regulation of the interleukin-6 gene of human herpesvirus 8 (Kaposi's sarcoma-associated herpesvirus). J. Virol., 76(16), 8252-8264.
58. DePamphilis, M. L. (1993). Origins of DNA replication that function in eukaryotic cells. Curr. Opin. Cell. Biol., 5(3), 434-441.
59. Dittmer, D., Stoddart, C., Renne, R. et al. (1999). Experimen-tal transmission of Kaposi's sarcoma-associated herpesvirus (KSHV/HHV-8)to SCID-hu Thy/Liv mice. J. Exp. Med., 190(12), 1857-1868.
60. Drexler, H., Uphoff, C., Gaidano, G., and Carbone, E. (1998). Lym-phoma cell lines: In vitro models for the study of HHV-8+ pri-mary effusion lymphomas (body cavity-based lymphomas). Leukemia, 12, 1507-1517.
61. Dupin, N., Fisher, C., Kellam, P. et al. (1999). Distribution of human herpesvirus-8 latently infected cells in Kaposi's sar-coma, multicentric Castleman's disease, and primary effusion lymphoma. Proc. Natl Acad. Sci. USA, 96, 4546-4551.
62. Duus, K. M., Lentchitsky, V., Wagenaar, T., Grose, C., and Webster-Cyriaque (2004). Wild-type Kaposi's sarcoma-associated her-pesvirus isolated from the oropharynx of immune-competent individuals has tropism for cultured oral epithelial cells. J. Virol., 78(8), 4074-4084.
63. Eltom, M. A., Jemal, A., and Mbulaiteye, S. M. (2002). Trends in Kaposi's sarcoma and non-Hodgkin's lymphoma incidence in the United States from 1973 through 1998. J. Natl Cancer Inst., 94(16), 1204-1210.
64. Engels, E. A., Biggar, R. J., Marshall, V. A. et al. (2003). Detec-tion and quanti?cation of Kaposi's sarcoma-associated her-pesvirus to predict AIDS-associated Kaposi's sarcoma. J. AIDS, 17(12), 1847-1851.
65. Ensoli, B., Nakamura, S., Salahuddin, S. et al. (1989). AIDS-Kaposi's Sarcoma-derived cells express cytokines with autocrine and paracrine growth effects. Science, 243, 223-226.
66. Ensoli, B., Sturzl, M., and Monini, P. (2000). Cytokine-mediated growth promotion of Kaposi's sarcoma and primary effusion lymphoma. Semin. Cancer Biol., 10, 367-381.
67. Ensoli, B., Sgadari, C., Barillari, G., Sirianni, M. C., Sturzl, M., and Monini, P. (2001). Biology of Kaposi's sarcoma. Eur. J. Cancer, 37(10), 1251-1269.
68. Ernst, M. and Jenkins, B. J. (2004). Acquiring signalling speci?city from the cytokine receptor gp130. Trends Genet., 20(1), 23-32. Fais, F., Gaidano, G., Capello, D. et al. (1999). Immunoglobulin V region gene use and structure suggest antigen selection in AIDS-related primary effusion lymphomas. Leukemia, 13(7), 1093-1099.
69. Fakhari, F. D. and Dittmer, D. P. (2002). Charting latency transcripts in Kaposi's sarcoma-associated herpesvirus by whole-genome real-time quantitative PCR. J. Virol., 76(12), 6213-6223.
70. Fardet, L., Blum, L., Kerob, D. et al. (2003). Human herpesvirus 8-associated hemophagocytic lymphohistiocytosis in human immunode?ciency virus-infected patients. Clin. Infect. Dis., 37(2), 285-291.
71. Farge, D., Lebbe, C., Marjanovic, Z. et al. (1999). Human herpes virus-8 and other risk factors for Kaposi's sarcoma in kidney transplant recipients. Groupe Cooperatif de Transplantation d Ile de France (GCIF). Transplantation, 67(9), 1236-1242.
72. Feng, P., Park, J., Lee, B. S. et al. (2002). Kaposi's sarcoma-associated herpesvirus mitochondrial K7 protein targets a cellular calcium-modulating cyclophilin ligand to modulate intracellular calcium concentration and inhibit apoptosis. J. Virol., 76(22), 11491-11504.
73. Feng, P., Scott, C. W., Cho, N. H. et al. (2004). Kaposi's sarcoma-associated herpesvirus K7 protein targets a ubiquitin-like/ubiquitin-associated domain-containing protien to pro-mote protein degradation. Mol. Cell. Biol., 24(9), 3938-3948.
74. Feske, S., Okamura, H., Hogan, P. G., and Rao, A. (2003). Ca2+ /calcineurin signalling in cells of the immune system. Biochem. Biophys. Res. Commun., 311(4), 1117-1132.
75. Field, A. K., Davies, M. E., DeWitt, C. et al. (1983). 9-([2-hydroxy-1-(hydroxymethyl)ethoxy]methyl)guanine: A selective inhibitor of herpes group virus replication. Proc. Natl Acad. Sci. USA, 80(13), 4139-4143.
76. Fixman, E. D., Hayward, G. S., and Hayward, S. D.(1995). Replication of Epstein-Barr virus oriLyt: Lack of a dedicated virally encoded origin-binding protein and dependence on Zta in cotransfec-tion assays. J. Virol., 69(5), 2998-3006.
77. Flemington, E. K. (2001). Herpesvirus lytic replication and the cell cycle: Arresting new developments. J. Virol., 75(10), 4475-4481.
78. Flowers, C. C., Flowers, S. P., and Nabel, G. J. (1998). Kaposi's sarcoma-associated herpesvirus viral interferon regulatory actor confers resistance to the antiproliferative effect of interferon-alpha. Mol. Med., 4(6), 402-412.
79. Gaidano, G., Cechova, K., Chang, Y., Moore, P. S., Knowles, D. M., and Dalla-Favera, R. (1996). Establishment of AIDS-related lym-phoma cell lines from lymphomatous effusions. Leukemia, 10(7), 1237-1240.
80. Gangappa, S., Kapadia, S. B., Speck, S. H., and Virgin, H. W. T. (2002). Antibody to a lyticcycle viral protein decreases gamma-herpesvirus latency in B-cell-de?cient mice. J. Virol., 76(22), 11460-11468.
81. Gao, S. J., Kingsley, L., Hoover, D. R. et al. (1996a). Seroconversion to antibodies against Kaposi's sarcoma-associated herpesvirus-related latent nuclear antigens before the development of Kaposi's sarcoma. N. Engl. J. Med., 335(4), 233-241.
82. Gao, S. J., Kingsley, L., Li, M. et al. (1996b). KSHV antibodies among Americans, Italians and Ugandans with and without Kaposi's sarcoma. Nat. Med., 2(8), 925-928.
83. Gao, S. J., Boshoff, C., Jayachandra, S., Weiss, R. A., Chang, Y., and Moore, P. S. (1997). KSHV ORF K9 (vIRF) is an oncogene which inhibits the interferon signaling pathway. Oncogene, 15(16), 1979-1985.
84. Ghosh, S. K., Wood, C., Boise, L. H. et al. (2003). Potentiation of TRAIL-induced apoptosis in primary effusion lymphoma through azidothymidine-mediated inhibition of NF-kappa B. Blood, 101(6), 2321-2327.
85. Gill, J., Bourboulia, D., Wilkinson, J. et al. (2002). Prospective study of the effects of antiretroviral therapy on Kaposi sarcoma-associated herpesvirus infection in patients with and without Kaposi sarcoma. J. Acquir. Immune De?c. Syndr., 31(4), 384-390.
86. Glaunsinger, B. and Ganem, D. (2004). Highly selective escape from KSHV-mediated host mRNA shutoff and its implications for viral pathogenesis. J. Exp. Med., 200(3), 391.
87. Gradoville, L., Gerlach, J., Grogan, E. et al. (2000). Kaposi's sarcoma-associated herpesvirus open reading frame 50/Rta protein activates the entire lytic cycle in the HH-B2 primary effusion lymphoma cell line. J. Virol., 74, 6207-6212.
88. Grandadam, M., Dupin, N., Calvez, V. et al. (1997). Exacerba-tions of clinical symptoms in human immunode?cinecy virus type 1-infected patients with multicentric Castleman's disease are associated with a high increase in Kaposi's sarcoma her-pesvirus DNA load in peripheral blood mononuclear cells. J. Infect. Dis., 175(5), 1198-1201.
89. Gwack, Y., Byun, H., Hwang, S., Lim, C., and Choe, J. (2001a). CREB-binding protein and histone deacetylase regulate the tran-scriptionalactivityof Kaposi's sarcoma-associatedherpesvirus open reading frame 50. J. Virol., 75(4), 1909-1917.
90. Gwack, Y., Hwang, S., Byun, H. et al. (2001b). Kaposi's sarcoma-associated herpesvirus open reading frame 50 represses p53-induced transcriptional activity and apoptosis. J. Virol., 75(13), 6245-6248.
91. Gwack, Y., Hwang, S., Lim, C., Won, Y. S., Lee, C. H., and Choe, J. (2002). Kaposi's Sarcoma-associated Herpesvirus Open Read-ing Frame 50 Stimulates the Transcriptional Activity of STAT3. J. Biol. Chem., 277(8), 6438-6442.
92. Gwack, Y., Baek, H. J., Nakamura, H. et al. (2003a). Principal role of TRAP/mediator and SWI/SNF complexes in Kaposi's sarcoma-associated herpesvirus RTA-mediated lytic reactivation. Mol. Cell. Biol., 23(6), 2055-2067.
93. Gwack, Y., Nakamura, H., Lee, S. H. et al. (2003b). Poly(ADP-ribose) polymerase 1 and Ste20-like kinase hKFC act as transcriptional repressors for gamma-2 herpesvirus lytic replication. Mol. Cell. Biol., 23(22), 8282-8294.
94. Hammerschmidt, W. and Sugden, B. (1988). Identification and characterization of oriLyt, a lytic origin of DNA replication of Epstein-Barr virus. Cell, 55(3), 427-433.
95. Haque, M., Davis, D. A., Wang, V., Widmer, I., and Yarchoan, R. (2003). Kaposi's sarcoma-associated herpesvirus (human her-pesvirus 8) contains hypoxia response elements: Relevance to lytic inducation by hypoxia. J. Virol., 77(12), 6761-6768.
96. Han, Z. and Swaminathan, S. (2006). Kaposi's sarcoma-associated herpesvirus lytic gene ORF57 is essential for infectious virion production. J. Virol., 80(11), 5251-5260.
97. Harrington, W. J., Jr., Bagasra, O., Sosa, C. et al. (1996). Human herpesvirus type 8 DNA sequences in cell-free plasma and mononuclear cells of Kaposi's sarcoma patients. J. Infect. Dis., 174(5), 1101-1105.
98. Harrington, W., Jr., Sieczkowski, L., Sosa, C. et al. (1997). Activation of HHV-8 by HIV-1 tat. Lancet, 349(9054), 774-775.
99. Hengge, U. R., Ruzicka, T., Tyring, S. K. et al. (2002). Update on Kaposi's sarcoma and other HHV8 associated diseases. Part 1: Epidemiology, environmental predispositions, clinical mani-festations, and therapy. Lancet Infect. Dis., 2(5), 281-292.
100. Henry, M., Uthman, A., Geusau, A. et al. (1999). Infection of circulat-ing CD34+ cells by HHV-8 in patients with Kaposi's sarcoma. J. Invest. Dermatol., 113(4), 613-616.
101. Huang, L. M., Chao, M. F., Chen, M. F. et al. (2001). Reciprocal reg-ulatory interaction between human herpesvirus 8 and human immunode?ciency virus type 1. J. Biol. Chem., 276(16), 13427-13432.
102. Humphrey, R. W., O'Brien, T. R., Newcomb, F. M. et al. (1996). Kaposi's sarcoma (KS)-associated herpesvirus-like DNA sequences in peripheral blood mononuclear cells: Association with KS and persistence in patients receiving anti-herpesvirus drugs. Blood, 88(1), 297-301.
103. Inohara, N., Gourley, T. S., Carrio, R. et al. (1998). Diva, a Bcl-2 homologue that binds directly to Apaf-1 and induces BH3-independent cell death. J. Biol. Chem., 273(49), 32479-32486.
104. Iscovich, J., Boffetta, P., Franceschi, S., Azizi, E., and Sarid, R. (2000). Classic Kaposi sarcoma. Cancer, 88, 500-517.
105. Izumiya, Y., Lin, S. F., Ellison, T. et al. (2003a). Kaposi's sarcoma-associated herpesvirus K-bZIP is a coregulator of K-Rta: Physical association and promoter-dependent transcriptional repression. J. Virol., 77(2), 1441-1451.
106. Izumiya, Y., Lin, S. F., Ellison, T. J. et al. (2003b). Cell cycle regulation by Kaposi's sarcoma-associated herpesvirus K-bZIP: Direct interaction with cyclin-CDK2 and induction of G1 growth arrest. J. Virol., 77(17), 9652-9661.
107. Jacobson, L. P., Jenkins, F. J., Springer, G. et al. (2000). Interac-tion of human immunode?ciency virus type 1 and human herpesvirus type 8 infections on the incidence of Kaposi's sar-coma. J. Infect. Dis., 181(16), 1940-1949.
108. Jayachandra, S., Low, K. G., Thick, A. E. et al. (1999). Three unrelated viral transforming proteins (vIRF, EBNA2, and E1A) induce the MYC oncogene through the interferon-responsive PRF ele-ment by using different transcription coadaptors. Proc. Natl Acad. Sci. USA, 96(20), 11566-11571.
109. Jenkins, P., Binne, U., and Farrell, P. (2000). Histone acetylation and reactivation of Epstein-Barr virus from latency. J. Virol., 74, 710-720.
110. Jenner, R., Alba, M., Boshoff, C., and Kellam, P. (2001). Kaposi's sarcoma-associated herpesvirus latent and lytic gene expres-sion as revealed by DNA arrays. J. Virol, 75, 891-902.
111. Jenner, R. G., Maillard, K., Cattini, N. et al. (2003). Kaposi's sarcoma-associated herpesvirus-infected primary effusion lymphoma has a plasma cell gene expression pro?le. Proc. Natl Acad. Sci. USA, 100(18), 10399-10404.
112. Jones, J. L., Hanson, D. L., Chu, S. Y., Ward, J. W., and Jaffe, H. W. (1995). AIDS-associated Kaposi's sarcoma. Science, 267(5201), 1078-1079.
113. Jones, J. L., Hanson, D. L., Dworkin, M. S., and Jaffe, H. W. (2000). Incidence and trends in Kaposi's sarcoma in the era of effective antiretroviral therapy. J. Acquir. Immune De?c. Syndr., 24(3), 270-274.
114. Kaufman, D. B., Shapiro, R., Lucey, M. R. et al. (2004). Immunosuppression: Practice and trends. Am. J. Transpl., 4 Suppl 9, 38-53.
115. Kedes, D. H. and Ganem, D. (1997). Sensitivity of Kaposi's sarcoma-associated herpesvirus replication to antiviral drugs. Implica-tions for potential therapy. J. Clin. Invest., 99(9), 2082-2086.
116. Kedes, D., Operskalski, E., Busch, M., Kohn, R., Flood, J., and Ganem, D. (1996). The seroepidemiology of human her-pesvirus 8 (Kaposi's sarcoma-associated herpesvirus): Distri-bution of infection in KS risk groups and evidence for sexual transmission. Nat. Med., 2, 918-924.
117. Keller, S. A., Schattner, E. J., and Cesarman, E. (2000). Inhibition of NF-kappaB induces apoptosis of KSHV-infected primary effusion lymphoma cells. Blood, 96(7), 2537-2542.
118. Keller, R., Zago, A., Viana, M. C. et al. (2001). HHV-8 infection in patients with AIDS-related Kaposi's sarcoma in Brazil. Braz. J. Med. Biol. Res., 34(7), 879-886.
119. Kikuta, H., Itakura, O., Taneichi, K., and Kohno, M. (1997). Tropism of human herpesvirus 8 for peripheral blood lymphocytes in patients with Castleman's disease. Br. J. Haematol., 99(4), 790-793.
120. Kim, I. J., Flano, E., Woodland, D. L., and Blackman, M. A. (2002). Antibody-mediated control of persistent gamma-herpesvirus infection. J. Immunol., 168(8), 3958-3964.
121. Kimball, L. E., Casper, C., Koelle, D. M., Morrow, R., Corey, L., and Vieira, J. (2004). Reduced levels of neutralizing antibod-ies to Kaposi sarcoma-associated herpesvirus in persons with a history of Kaposi sarcoma. J. Infect. Dis., 189(11), 2016-2022.
122. Kirchhoff, S., Sebens, T., Baumann, S. et al. (2002). Viral IFN-regulatory factors inhibit activation-induced cell death via two positive regulatory IFN-regulatory factor 1-dependent domains in the CD95 ligand promoter. J. Immunol., 168(3), 1226-1234.
123. Kirshner, J. R., Lukac, D. M., Chang, J., and Ganem, D. (2000). Kaposi's sarcoma-associated herpesvirus open reading frame 57 encodes a posttranscriptional regulator with multiple dis-tinct activities. J. Virol., 74, 3586-3597.
124. Klein, U., Gloghini, A., Gaidano, G. et al. (2003). Gene expression pro?le analysis of AIDS-related primary effusion lymphoma (PEL) suggests a plasmablastic derivation and identi?es PEL-speci?c transcripts. Blood, 101(10), 4115-4121.
125. Koelle, D. M., Huang, M. L., Chandran, B., Vieira, J., Piepkorn, M., and Corey, L. (1997). Frequent detection of Kaposi's sarcoma-associated herpesvirus (human herpesvirus 8) DNA in saliva of human immunode?ciency virus-infected men: Clinical and immunologic correlates. J. Infect. Dis., 176(1), 94-102.
126. LaDuca, J. R., Love, J. L., Abbott, L. Z., Dube, S., Freidman-Kien, A. E., and Poiesz, B. J. (1998). Detection of human herpesvirus 8 DNA sequences in tissues and bodily ?uids. J. Infect. Dis., 178(6), 1610-1615.
127. Lagunoff, M., Majeti, R., Weiss, A., and Ganem, D. (1999). Deregu-lated signal transduction by the K1 gene product of Kaposi's sarcoma-associated herpesvirus. Proc. Natl Acad. Sci. USA, 96(10), 5704-5709.
128. Lagunoff, M., Lukac, D., and Ganem, D. (2001). Immunorecep-tor tyrosine-based activation motif-dependent signaling by Kaposi's sarcoma-associated herpesvirus (KSHV) K1 protein: Effects on lytic viral replication. J. Virol., 75, 5891-5898.
129. Lan, K., Kuppers, D. A., and Robertson, E. S. (2005). Kaposi's sarcoma-associated herpesvirus reactivation is regulated by interaction of latency-associated nuclear antigen with recom-bination signal sequence-binding protein Jk, the major down-stream effector of the notch signaling pathway. J. Virol., 79(6), 3468-3478.
130. Lebbe, C., Blum, L., Pellet, C. et al. (1998). Clinical and biological impact of antiretroviral therapy with protease inhibitors on HIV-related Kaposi's sarcoma. AIDS, 12(7), F45-F49.
131. Lee, B. S., Paulose-Murphy, M., Chung, Y. H. et al. (2002). Suppression of tetradecanoyl phorbol acetate-induced lytic reactivation of Kaposi's sarcoma-associated herpesvirus by K1 signal transduction. J. Virol., 76(23), 12185-12199.
132. Lee, H., Guo, J., Li, M. et al. (1998). Identification of an immunore-ceptor tyrosine-based activation motif of K1 transforming pro-tein of Kaposi's sarcoma-associated herpesvirus. Mol. Cell. Biol., 18(9), 5219-5228.
133. Leonard, W. J. and Oshea, J. J. (1998). Jaks and STATs: Biological implications. Annu. Rev. Immunol., 16, 293-322.
134. Li, M., Lee, H., Guo, J. et al. (1998). Kaposi's sarcoma-associated herpesvirusviralinterferonregulatoryfactor. J. Virol., 72, 5433-5440.
135. Liang, Y. and Ganem, D. (2003). Lytic but not latent infection by Kaposi's sarcoma-associated herpesvirus requires host CSL protein, the mediator of Notch signaling. Proc. Natl Acad. Sci. USA, 100(14), 8490-8495.
136. Liang, Y. and Ganem, D. (2004). RBP-J (CSL) is essential for activation of the K14/vGPCR promoter of Kaposi's sarcoma-associated herpesvirus by the lytic switch protein RTA. J. Virol., 78(13), 6818-6826.
137. Liang, Y., Chang, J., Lynch, S., Lukac, D. M., and Ganem, D. (2002). The lytic switch protein of KSHV activates gene expression via functional interaction with RBP-Jk, the tar-get of the Notch signaling pathway. Genes Dev., 16, 1977-1989.
138. Liao, W., Tang, Y., Kuo, Y. L. etal.(2003). Kaposi's sarcoma-associated herpesvirus/human herpesvirus 8 transcriptional activator Rta is an oligomeric DNA-binding protein that interacts with tandem arrays of phased A/T-trinucleotide motifs. J. Virol., 77(17), 9399-9411.
139. Lin, C. L., Li, H., Wang, Y., Zhu, F. X., Kudchodkar, S., and Yuan, Y. (2003). Kaposi's sarcoma-associated herpesvirus lytic origin (ori-Lyt)-dependent DNA replication: Identification of the ori-Lyt and association of K8 bZip protein with the origin. J. Virol., 77(10), 5578-5588.
140. Lin, K., Dai, C. Y., and Ricciardi, R. P. (1998). Cloning and func-tional analysis of Kaposi's sarcoma-associated herpesvirus DNA polymerase and its processivity factor. J. Virol., 72, 6228-6232.
141. Lin, R., Genin, P., Mamane, Y. et al. (2001). HHV-8 encoded vIRF-1 represses the interferon antiviral response by blocking IRF-3 recruitment of the CBP/p300 coactivators. Oncogene, 20(7), 800-811.
142. Lo, P., Yu, X., Atanasov, I., Chandran, B., and Zhou, Z. H. (2003). Three-dimensional localization of pORF65 in Kaposi's sarcoma-associated herpesvirus capsid. J. Virol., 77(7), 4291-4297.
143. Lu, F., Zhou, J., Wiedmer, A., Madden, K., Yuan, Y., and Lieberman, P. M. (2003). Chromatin remodeling of the Kaposi's sarcoma-associated herpesvirus ORF50 promoter correlates with reac-tivation from latency. J. Virol., 77(21), 11425-11435.
144. Lu, M., Suen, J., Frias, C. et al. (2004). Dissection of the Kaposi's sarcoma-associated gene expression program using the viral DNA replication inhibitor cidofovir. J. Virol., 78(24), 13637-13652.
145. Lukac, D. M., Renne, R., Kirshner, J. R., and Ganem, D. (1998). Reac-tivation of Kaposi's sarcoma-associated herpesvirus infection from latency by expression of the ORF 50 transactivator, a homolog of the EBV R protein. Virology, 252, 304-312.
146. Lukac, D. M., Kirshner, J. R., and Ganem, D. (1999). Transcriptional activation by the product of the open reading frame 50 of Kaposi's-associated herpesvirus is required for lytic viral reac-tivation inB cells. J. Virol., 73, 9348-9361.
147. Lukac, D., Garibyan, L., Kirshner, J., Palmeri, D., and Ganem, D. (2001). DNA binding by the Kaposi's sarcoma-associated her-pesvirus lytic switch protein is necessary for transcriptional activation of two viral delayed early promoters. J. Virol., 75, 6786-6799.
148. Luppi, M., Barozzi, P., Guaraldi, G. et al. (2003). Human herpesvirus 8-associated diseases in solid-organ transplantation: Impor-tance of viral transmission from the donor. Clin. Infect. Dis., 37(4), 606-607; author reply 607.
149. Mantina, H., Kankasa, C., Klaskala, W. et al. (2001). Vertical trans-mission of Kaposi's sarcoma-associated herpesvirus. Int. J. Cancer, 94(5), 749-752.
150. Martin, D. F., Kuppermann, B. D., Wolitz, R. A., Palestine, A. G., Li, H., and Robinson, C. A. (1999). Oral ganciclovir for patients with cytomegalovirus retinitis treated with a ganciclovir implant. Roche Ganciclovir Study Group. N. Engl. J. Med., 340, 1063-1070.
151. Martin, J. N., Ganem, D. E., Osmond, D. H. et al. (1998). Sexual transmission and the natural history of human herpesvirus 8 infection. N. Engl. J. Med., 338, 948-954.
152. Maulik, G., Shrikhande, A., Kijima, T., Ma, P. C., Morrison, P. T., and Salgia, R. (2002). Role of the hepatocyte growth factor receptor, c-Met, in oncogenesis and potential for therapeutic inhibition. Cytokine Growth Factor Rev., 13(1), 41-59.
153. McGeoch, D. J. and Davison, A. J. (1999). The descent of human herpesvirus 8. Semin. Cancer Biol., 9(3), 201-209.
154. Merat, R., Amara, A., de The, H., Morel, P., and Saib, A. (2002). HIV-1 infection of primary effusion lymphoma cell line triggers Kaposi's sarcoma-associated herpesvirus (KSHV) reactivation. Int. J. Cancer, 97(6), 791-795.
155. Mercader, M., Taddeo, B., Panella, J., Chandran, B., Nickoloff, B., and Foreman, K. (2000). Induction of HHV-8 lytic cycle replication by in?ammatory cytokines produced by HIV-1-infected T cells. Am. J. Pathol., 156, 1961-1971.
156. Miles, S. A., Martinez-Maza, O., Rezai, A. et al. (1992). Oncostatin M as a potent mitogen for AIDS-Kaposi's sarcoma-derived cells. Science, 255(5050), 1432-1434.
157. Miller, G., Heston, L., Grogan, E. et al. (1997). Selective switch between latency and lytic replication of Kaposi's sarcoma her-pesvirus and Epstein-Barr virus in dually infected body cavity lymphoma cells. J. Virol., 71(1), 314-324.
158. Mocroft, A., Kirk, O., Clumeck, N. et al. (2004). The changing pat-tern of Kaposi sarcoma in patients with HIV, 1994-2003: The EuroSIDA Study. Cancer, 100(12), 2644-2654.
159. Monini, P., Carlini, F., Sturzl, M. et al. (1999a). Alpha interferon inhibits human herpesvirus 8 (HHV-8) reactivation in primary effusion lymphoma cells and reduces HHV-8 load in cultured peripheral bloodmononuclear cells. J. Virol., 73(5), 4029-4041.
160. Monini, P., Colombini, S., Sturzl, M. et al. (1999b). Reactivation and persistence of human herpesvirus-8 infection in B cells and monocytes by Th-1 cytokines increased in Kaposi's sarcoma. Blood, 93(12), 4044-4058.
161. Monini, P., Sirianni, M. C., Franco, M. et al. (2001). Clear-ance of human herpesvirus 8 from blood and regression of leukopenia-associated aggressive classic Kaposi's sarcoma during interferon-alpha therapy: A case report. Clin. Infect. Dis., 33(10), 1782-1785.
162. Moore, P. S. and Chang, Y. (1995). Detection of herpesvirus-like DNA sequences in Kaposi's sarcoma in patients with and without HIV infection. N. Engl. J. Med., 332(18), 1181-1185.
163. Moore, P. S., Kingsley, L. A., Holmberg, S. D. et al. (1996). Kaposi's sarcoma-associated herpesvirus infection prior to onset of Kaposi's sarcoma. AIDS, 10, 175-180.
164. Nador, R. G., Cesarman, E., Chadburn, A. et al. (1996). Primary effusion lymphoma: A distinct clinicopathologic entity associ-ated with the Kaposi's sarcoma-associated herpes virus. Blood, 88(2), 645-656.
165. Naidu, Y. M., Rosen, E. M., Zitnick, R. et al. (1994). Role of scatter factor in the pathogenesis of AIDS-related Kaposi sarcoma. Proc. Natl Acad. Sci. USA, 91(12), 5281-5285.
166. Nakamura, H., Li, M., Zarycki, J., and Jung, J. U. (2001). Inhibition of p53 tumor suppressor by viral interferon regulatory factor. J. Virol., 75(16), 7572-7582.
167. Nakamura, H., Lu, M., Gwack, Y., Souvlis, J., Zeichner, S. L., and Jung, J. U. (2003). Global changes in Kaposi's sarcoma-associated virusgeneexpressionpatterns followingexpression of a tetracycline-inducible Rta transactivator. J Virol., 77(7), 4205-4220.
168. Nasti, G., Martellotta, F., Berretta, M. et al. (2003). Impact of highly active antiretroviral therapy on the presenting features and outcome of patients with acquired immunode?ciency syndrome-related Kaposi sarcoma. Cancer, 98(11), 2440-2446.
169. Nealon, K., Newcomb, W. W., Pray, T. R. et al. (2001). Lytic replica-tion of Kaposi's sarcoma-associated herpesvirus results in the formation of multiple capsid species: Isolation and molecu-lar characterization of A, B, and C capsids from a gammaher-pesvirus. J. Virol., 75(6), 2866-2878.
170. Niedt, G. W., Myskowski, P. L., Urmacher, C., Niedzwiecki, D., Chap-man, D., and Safai, B. (1990). Histology of early lesions of AIDS-associated Kaposi's sarcoma. Mod. Pathol., 3(1), 64-70.
171. Nishimura, K., Ueda, K., Sakakibara, S. etal. (2003). A viraltranscrip-tional activator of Kaposi's sarcoma-associated herpesvirus (KSHV) induces apoptosis, which is blocked in KSHV-infected cells. Virology, 316(1), 64-74.
172. Nuovo, M. and Nuovo, G. (2001). Utility of HHV8 RNA detection for differentiating Kaposi's sarcoma from its mimics. J. Cutan. Pathol., 28(5), 248-255.
173. Oksenhendler, E., Carcelain, G., Aoki, Y. et al. (2000). High lev-els of human herpesvirus 8 viral load, human interleukin-6, interleukin-10, and C reactive protein correlate with exac-erbation of multicentric castleman disease in HIV-infected patients. Blood, 96(6), 2069-2073.
174. Osmond, D. H., Buchbinder, S., Cheng, A. et al. (2002). Preva-lence of Kaposi sarcoma-associated herpesvirus infection in homosexual menat beginningof and during the HIV epidemic. J. Am. Med. Assoc., 287(2), 221-225.
175. Parravicini, C., Olsen, S. J., Capra, M. et al. (1997). Risk of Kaposi's sarcoma herpesvirus transmission from donor allo-grafts among Italian posttransplant Kaposi's sarcoma patients. Blood, 90, 2826-2829.
176. Pauk, J., Huang, M. L., Brodie, S. J. et al. (2000). Mucosal shedding of human herpesvirus 8 in men. N. Engl. J. Med., 343(19), 1369-1377.
177. Paulose-Murphy, M., Ha, N.-K., Xiang, C. et al. (2001). Transcrip-tion program of Human herpesvirus 8 (Kaposi's Sarcoma-associated herpesvirus). J. Virol., 75, 4843-4853.
178. Pellet, C., Chevret, S., Blum, L. et al. (2001). Virologic and immuno-logic parameters that predict clinical response of AIDS-associated Kaposi's sarcoma to highly active antiretroviral therapy. J. Invest. Dermatol., 117(4), 858-863.
179. Pertel, P. E. (2002). Human herpesvirus 8 glycoprotein B (gB), gH, and gL can mediate cell fusion. J. Virol., 76(9), 4390-4400.
180. Picchio, G. R., Sabbe, R. E., Gulizia, R. J. et al. (1997). The KSHV/HHV8-infected BCBL-1 lymphoma line causes tumors in SCID mice but fails to transmit virus to a human peripheral blood mononuclear cell graft. Virology, 238(1), 22-29.
181. Polson, A., Huang, L., Lukac, D. et al. (2001). Kaposi's sarcoma-associated herpesvirus K-bZIP protein is phosphorylated by cyclin-dependent kinases. J. Virol., 75, 3175-3184.
182. Polstra, A. M., Goudsmit, J., and Cornelissen, M. (2003). Latent and lytic HHV-8 mRNA expression in PBMCs and Kaposi's sarcoma skin biopsies of AIDS Kaposi's sarcoma patients. J. Med. Virol., 70(4), 624-627.
183. Pyakurel, P., Massambu, C., Castanos-Velez, E. et al. (2004). Human herpesvirus 8/Kaposi sarcoma herpesvirus cell association during evolution of Kaposi sarcoma. J. Acquir. Immune De?c. Syndr., 36(2), 678-683.
184. Quinlivan, E. B., Zhang, C., Stewart, P. W., Komoltri, C., Davis, M. G., and Wehbie, R. S. (2002). Elevated virus loads of Kaposi's sarcoma-associated human herpesvirus 8 predict Kaposi's sarcoma disease progression, but elevated levels of human immunode?ciency virus type 1 do not. J. Infect. Dis., 185(12), 1736-1744.
185. Reed, J. A., Nador, R. G., Spaulding, D., Tani, Y., Cesarman, E., and Knowles, D. M. (1998). Demonstration of Kaposi's sarcoma-associated herpesvirus cyclin D homolog in cuta-neous Kaposi's sarcoma by colorimetric in situ hybridization using a catalyzed signal ampli?cation system. Blood, 91(10), 3825-3832.
186. Renne, R., Lagunoff, M., Zhong, W., and Ganem, D. (1996a). The size and conformation of Kaposi's sarcoma-associated herpesvirus (human herpesvirus 8) DNA in infected cells and virions. J. Virol., 70(11), 8151-8154.
187. Renne, R., Zhong, W., Herndier, B. et al. (1996b). Lytic growth of Kaposi's sarcoma-associated herpesvirus (human herpesvirus 8) in culture. Nat. Med., 2(3), 342-346.
188. Renne, R., Blackbourn, D., Whitby, D., Levy, J., and Ganem, D. (1998). Limited transmission of Kaposi's sarcoma-associated herpesvirus in cultured cells. J. Virol., 72, 5182-5188.
189. Rimessi, P., Bonaccorsi, A., Sturzl, M. et al. (2001). Transcription pattern of human herpesvirus 8 open reading frame K3 in primary effusion lymphoma and Kaposi's sarcoma. J. Virol., 75(15), 7161-7174.
190. Robertson, K. A., Usherwood, E. J., and Nash, A. A. (2001). Regression of a murine gammaherpesvirus 68-positive b-cell lymphoma mediated by CD4 T lymphocytes. J. Virol., 75(7), 3480-3482.
191. Robles, R., Lugo, D., Gee, L., and Jacobson, M. A. (1999). Effect of antiviral drugs used to treat cytomegalovirus end-organ dis-ease on subsequent course of previously diagnosed Kaposi's sarcoma in patients with AIDS. J. Acquir. Immune De?c. Syndr. Hum. Retrovirol., 20(1), 34-38.
192. Roizman, B. and Sears, A. E.(1996). Herpes simplex viruses and their replication. In Fields, B. N., Knipe, D. M., Howley, P. M. et al. eds Fields Virology. Philadelphia, Lippincott-Raven Publishers, pp. 2231-2295.
193. Sakakibara, S., Ueda, K., Chen, J., Okuno, T., and Yamanishi, K. (2001). Octamer-binding sequence is a key element for the autoregulation of Kaposi's sarcoma-associated herpesvirus ORF50/Lyta gene expression. J. Virol., 75, 6894-6900.
194. Sakurada, S., Katano, H., Sata, T., Ohkuni, H., Watanabe, T., and Mori, S. (2001). Effective human herpesvirus 8 infection of human umbilical vein endothelial cells by cell-mediated trans-mission. J. Virol., 75(16), 7717-7722.
195. Santarelli, R., DeMarco, R., Masala, M. et al. (2001). Direct correla-tion between human herpesvirus-8 seroprevalence and classic Kaposi's sarcoma incidence in Northern Sardinia. J. Med. Virol., 65, 368-372.
196. Sarawar, S. R., Lee, B. J., Reiter, S. K., and Schoenberger, S. P. (2001). Stimulation via CD40 can substitute for CD4 T cell function in preventing reactivation of a latent herpesvirus. Proc. Natl Acad. Sci. USA, 98(11), 6325-6329.
197. Sarid, R., Sato, T., Bohenzky, R. A., Russo, J. J., and Chang, Y. (1997). Kaposi's sarcoma-associated herpesvirus encodes a functional bcl-2 homologue. Nat. Med., 3(3), 293-298.
198. Sarid, R., Flore, O., Bohenzky, R. A., Chang, Y., and Moore, P. S.(1998). Transcription mapping of the Kaposi's sarcoma-associated herpesvirus (Human Herpesvirus 8) genome in a body cavity-based lymphoma cell line (BC-1). J. Virol., 72, 1005-1012.
199. Sarid, R., Olsen, S. J., and Moore, P. S. (1999). Kaposi's sarcoma-associated herpesvirus: Epidemiology, virology, and molecular biology. Adv. Virus Res., 52, 139-232.
200. Saveliev, A., Zhu, F., and Yuan, Y. (2002). Transcription mapping and expression patterns of genes in the major immediate-early region of Kaposi's sarcoma-associated herpesvirus. Virology, 299(2), 301-314.
201. Schalling, M., Ekman, M., Kaaya, E. E., Linde, A., and Biber?eld, P. (1995). A role fora new herpes virus (KSHV) in different forms of Kaposi's sarcoma. Nat. Med., 1(7), 707-708.
202. Seaman, W., Ye, D., Wang, R., Hale, E., Weisse, M., and Quinlivan, E. (1999). Gene expression from the ORF50/K8 region of Kaposi's sarcoma-associated herpesvirus. Virology, 263, 436-449.
203. Seo, T., Park, J., Lee, D., Hwang, S. G., and Choe, J. (2001). Viral interferon regulatory factor 1 of Kaposi's sarcoma-associated herpesvirus binds to p53 and represses p53-dependent tran-scription and apoptosis. J. Virol., 75(13), 6193-6198.
204. Serraino, D., Tedeschi, R. M., Songini, M. et al. (2000). Prevalence of antibodies to human herpesvirus 8 in children from Sardinia and Croatia. Infection, 28(5), 336-338.
205. Sgadari, C., Barillari, G., Toschi, E. et al. (2002). HIV protease inhibitors are potent anti-angiogenic molecules and promote regression of Kaposi sarcoma. Nat. Med., 8(3), 225-232.
206. Shahinian, A., Pfeffer, K., Lee, K. P. et al. (1993). Differential T cell costimulatory requirements in CD28-de?cient mice. Science, 261(5121), 609-612.
207. Shaw, R., Arbiser, J., and Offermann, M. K. (2000). Valproic acid induced human herpesvirus 8 lytic gene expression in BCBL-1 cells. AIDS, 14, 899.
208. Simas, J. and Efstathiou, S. (1998). Murine gammaherpesvirus 68: A model for the study of gammaherpesvirus pathogenesis. Trend Microbiol., 6, 276-282.
209. Simas, J. P., Swann, D., Bowden, R., and Efstathiou, S. (1999). Analy-sis of murine gammaherpesvirus-68 transcription during lytic and latent infection. J. Gen. Virol., 80(1), 75-82.
210. Sirianni, M. C., Uccini, S., Angeloni, A., Faggioni, A., Cottoni, F., and Ensoli, B. (1997). Circulating spindle cells: Correlation with human herpesvirus-8 (HHV-8) infection and Kaposi's sarcoma [letter]. Lancet, 349(9047), 255.
211. Sirianni, M. C., Vincenzi, L., Fiorelli, V. et al. (1998). Gamma-Interferon production in peripherala blood mononuclear cells and tumor in?ltrating lymphocytes from Kaposi's sar-coma patients: Correlation with the presence of human herpesvirus-8 in peripheral blood mononuclear cells and lesional macrophages. Blood, 91(3), 968-976.
212. Sirianni, M. C., Vincenzi, L., Topino, S. et al. (2002). NK cell activity controls human herpesvirus 8 latent infection and is restored upon highly active antiretroviral therapy in AIDS patients with regressing Kaposi's sarcoma. Eur. J. Immunol., 32(10), 2711-2720.
213. Song, M. J., Li, X., Brown, H. J., and Sun, R. (2002). Character-ization of interactions between RTA and the promoter of polyadenylated nuclear RNA in Kaposi's sarcoma-associated herpesvirus/human herpesvirus 8. J. Virol., 76(10), 5000-5013.
214. Song, M. J., Deng, H., and, Sun, R. (2003). Comparative study of regulation of RTA-responsive genes in Kaposi's sarcoma-associated herpesvirus/human herpesvirus 8. J. Virol., 77(17), 9451-9462.
215. Speck, S. and Virgin, H. I. (1999). Host and viral genetics of chronic infection: A mouse model of gamma-herpesvirus pathogene-sis. Curr. Opin. Microbiol., 2, 403-409.
216. Staskus, K. A., Zhong, W., Gebhard, K. et al. (1997). Kaposi's sarcoma-associated herpesvirus gene expression in endothe-lial (spindle) tumor cells. J. Virol., 71(1), 715-719.
217. Stevenson, P. G. and Doherty, P. C. (1998). Kinetic analysis of the speci?c host response to a murinegammaherpesvirus. J. Virol., 72(2), 943-949.
218. Stewart, J. P., Usherwood, E. J., Ross, A., Dyson, H., and Nash, T. (1998). Lung epithelial cells are a major site of murine gamma-herpesvirus persistence. J. Exp. Med., 187(12), 1941-1951.
219. Strauchen, J. A., Hauser, A. D., Burstein, D., Jimenez, R., Moore, P. S., and Chang, Y. (1996). Body cavity-based malignant lymphoma containing Kaposi sarcoma-associated herpesvirus in an HIV-negative man with previous Kaposi sarcoma. Ann. Intern. Med., 125(10), 822-825.
220. Strickler, H. D., Goedert, J. J., Bethke, F. R. et al. (1999). Human herpesvirus 8 cellular immune responses in homosexual men. J. Infect. Dis., 180(5), 1682-1685.
221. Sun, R., Lin, S. F., Staskus, K. et al. (1998). A viral gene that acti-vates lytic cycle expression of Kaposi's sarcoma-associated herpesvirus. Proc. Natl Acad. Sci. USA, 95, 10866-10871.
222. Sunil-Chandra, N., Efstathiou, S., Arno, J., and Nash, A. (1992a). Virological and pathological features of mice infected with murine gammaherpesvirus 68. J. Gen. Virol., 73, 2347-2356.
223. Sunil-Chandra, N., Efstathiou, S., and Nash, A. (1992b). Murine gammaherpesvirus 68 establishes a latent infection in mouse B lymphocytes in vivo. J. Gen. Virol., 73, 3275-3279.
224. Sunil-Chandra, N., Arno, J., Fazakerley, J., and Nash, A. (1994). Lym-phoproliferative disease in mice infected with murine gamma-herpesvirus 68. Am. J. Pathol., 145, 818-826.
225. Symensma, T. L., Martinez-Guzman, D., Jia, Q. et al. (2003). COX-2 induction during murine gammaherpesvirus 68 infection leads to enhancement of viral gene expression. J. Virol., 77(23), 12753-12763.
226. Taga, T. and Kishimoto, T. (1997). Gp130 and the interleukin-6 fam-ily of cytokines. Annu. Rev. Immunol., 15, 797-819.
227. Tam, H. K., Zhang, Z. F., Jacobson, L. P. et al. (2002). Effect of highly active antiretroviral therapy on survival among HIV-infected menwith Kaposi and sarcoma ornon-Hodgkin lymphoma. Int. J. Cancer, 98(6), 916-922.
228. Tedeschi, R., Enbom, M., Bidoli, E., Linde, A., De Pauli, P., and Dill-ner, J. (2001). Viral load of human herpesvirus 8 in peripheral blood of human immunode?ciency virus-infected patients with Kaposi's sarcoma. J. Clin. Microbiol., 39(12), 4269-4273.
229. Tibbetts, S. A., van Dyk, L. F. et al. (2002). Immune control of the number and reactivation phenotype of cells latently infected with a gammaherpesvirus. J. Virol., 76(14), 7125-7132.
230. Triantos, D., Horefti, E., Paximadi, E. et al. (2004). Presence of human herpes virus-8 in salvia and non-lesional oral mucosa in HIV-infected and oncologic immunocompromised patients. Oral Microbiol. Immunol., 19(3), 201-204.
231. Trus, B. L., Heymann, J. B., Nealon, K. et al. (2001). Capsid structure of Kaposi's sarcoma-associated herpesvirus, a gammaher-pesvirus, compared to those of an alphaherpesvirus, herpes simplex virus type 1, and a betaherpesvirus, cytomegalovirus. J. Virol., 75(6), 2879-2890.
232. Ubbink, D. T., II, Tulevski, den Hartog, D. et al. (1997). The value of non-invasive techniques for the assessment of critical limb ischaemia. Eur. J. Vasc. Endovasc. Surg., 13(3), 296-300.
233. Ueda, K., Ishikawa, K., Nishimura, K., Sakakibara, S., Do, E., and Yamanishi, K. (2002). Kaposi's sarcoma-associated herpesvirus (human herpesvirus 8) replication and transcription factor activates the K9 (vIRF) gene through two distinct cis elements by a non-DNA-binding mechanism. J. Virol., 76(23), 12044-12054.
234. Uphoff, C., Carbone, A., Gaidano, G., and Drexler, H. (1998). HHV-8 infection is speci?c for cell lines derived from primary effu-sion (body cavity-based) lymphomas. Leukemia, 12, 1806-1809.
235. Varthakavi, V., Browning, P. J., and Spearman, P. (1999). Human immunode?ciency virus replication in a primary effusion lymphoma cell line stimulates lytic-phase replication of Kaposi's sarcoma-associated herpesvirus. J. Virol., 73(12), 10329-10338.
236. Vieira, J. and O'Hearn, P. M. (2004). Use of the red ?uorescent pro-tein as a marker of Kaposi's sarcoma-associated herpesvirus lytic gene expression. Virology, 325(2), 225-240.
237. Vieira, J., Huang, M. L., Koelle, D. M., and Corey, L. (1997). Trans-missible Kaposi's sarcoma-associated herpesvirus (human herpesvirus 8) in saliva of men with a history of Kaposi's sarcoma [In Process Citation]. J. Virol., 71(9), 7083-7087.
238. Virgin, H. W. t., Latreille, P., Wamsley, P. et al. (1997). Complete sequence and genomic analysis of murine gammaherpesvirus 68. J. Virol., 71(8), 5894-5904.
239. Vitale, F., Viviano, E., Perna, A. et al. (2000). Serological and virologi-cal evidence of non-sexual transmission of human herpesvirus type 8 (HHV8). Epidemiol. Infect., 125, 671-675.
240. Wahren, B., Ruden, U., Gadler, H., Oberg, B., and Eriksson, B. (1985). Activity of the cytomegalovirus genome in the presence of PPi analogs. J. Virol., 56(3), 996-1001.
241. Wang, F. Z., Akula, S. M., Pramod, N. P., Zeng, L., and Chan-dran, B. (2001). Human herpesvirus 8 envelope glycoprotein K8.1A interaction with the target cells involves heparan sulfate. J. Virol., 75(16), 7517-7527.
242. Wang, H. W., Sharp, T. V., Kuomi, A., Koentges, G., and Boshoff, C. (2002). Characterization of an anti-apoptotic glycoprotein encoded by Kaposi's sarcoma-associated herpesvirus which resemblesasplicedvariantofhumansurvivin. EMBOJ., 21(11), 2602-2615.
243. Wang, S., Liu, S., Wu, M., Geng, Y., and Wood, C. (2001a). Kaposi's sarcoma-associated herpesvirus/human herpesvirus-8 ORF50 gene product contains a potent C-terminal activation domain which activates gene expression via a speci?c target sequence. Arch. Virol., 146(7), 1415-1426.
244. Wang, J., Zhang, J., Zhang, L., Harrington, Jr., W., West, J. T., and Wood, C. (2005). Modulation of human herpesvirus 8/Kaposi's sarcoma-associated herpesvirus replication and transcription activator transactivation by interferon regulatory factor 7. J. Virol., 79 (4), 2420-2431.
245. Wang, Y., Tang, Q., Maul, G. G., and Yuan, Y. (2006). Kaposi's sarcoma-associated herpesvirus ori-Lyt-dependent DNA replication: Dual roles of RTA in the replication. J. Virol., 80(24), 12171-12186.
246. Wang, S. E., Wu, F. Y., Fujimuro, M., Zong, J., Hayward, S. D., and Hayward, G. S. (2003a). Role of CCAAT/enhancer-binding protein alpha (C/EBPalpha) in activation of the Kaposi's sarcoma-associated herpesvirus (KSHV) lytic-cycle replication-associated protein (RAP) promoter in cooperation with the KSHV replication and transcription activator (RTA) and RAP. J. Virol., 77(1), 600-623.
247. Wang, S. E., Wu, F. Y., Yu, Y., and Hayward, G. S. (2003b). CCAAT/enhancer-binding protein-alpha is induced during the early stages of Kaposi's sarcoma-associated herpesvirus (KSHV) lytic cycle reactivation and together with the KSHV replication and transcription activator (RTA) cooperatively stimulates the viral RTA, MTA, and PAN promoters. J. Virol., 77(17), 9590-9612.
248. Wang, S. E., Wu, F. Y., Chen, H., Shamay, M., Zheng, Q., and Hayward, G. (2004). Early activation of the Kaposi's sarcoma-associated herpesvirus RTA, RAP, and MTApromoters by thetetradecanoyl phorbol acetate-induced AP1 pathway. J. Virol., 78(8), 4248-4267.
249. Wang, Y., Chong, O. T., and Yuan, Y. (2004a). Differential regulation of K8 gene expression in immediate-early and delayed-early stages of Kaposi's sarcoma-associated herpesvirus. Virology, 325(1), 149-163.
250. Wang, Y., Li, H., Chan, M. Y. et al. (2004b). Kaposi's sarcoma-associated herpesvirus ori-Lyt-dependent DNA replication: Cis-acting requirements for replication and ori-Lyt-associated RNA transcription. J. Virol., 78(16), 8615-8629.
251. Weck, K., Barkon, M., Yoo, L., Speck, S., and Virgin, H. I. (1996). Mature B cells are required for acute splenic infection, but not for establishment of latency, by murine gammaherpesvirus 68. J. Virol, 70, 6775-6780.
252. Weck, K. E., Dal Canto, A. J., Gould, J. D. et al. (1997). Murine gamma-herpesvirus 68 causes severe large-vessel arteritis in mice lacking interferon-gamma responsiveness:a new model for virus-induced vascular disease. Nat. Med., 3(12), 1346-1353.
253. Weck, K. E., Kim, S. S., Virgin, H. I., and Speck, S. H. (1999a). B cells regulate murine gammaherpesvirus 68 latency. J. Virol., 73(6), 4651-4661.
254. Weck, K. E., Kim, S. S., Virgin, H. I., and Speck, S. H. (1999b). Macrophages are the major reservoir of latent murine gamma-herpesvirus 68 in peritoneal cells. J. Virol., 73(4), 3273-3783.
255. Weigert, A. L., Pires, A., Adragao, T. et al. (2004). Human herpes virus-8 serology and DNA analysis in recipients of renal allo-grafts showing Kaposi's sarcoma and their respective donors. Transpl. Proc., 36(4), 902-904.
256. Whitby, D., Howard, M. R., Tenant-Flowers, M. et al. (1995). Detec-tion of Kaposi sarcoma associated herpesvirus in periph-eral blood of HIV-infected individuals and progression to Kaposi's sarcoma [see comments]. Lancet, 346(8978), 799-802.
257. Wilkinson, J., Cope, A., Gill, J. et al. (2002). Identification of Kaposi's sarcoma-associated herpesvirus (KSHV)-speci?c cytotoxic T-lymphocyte epitopes and evaluation of reconstitution of KSHV-speci?c responses in human immunode?ciency virus type 1-infected patients receiving highly active antiretroviral therapy. J. Virol., 76(6), 2634-2640.
258. Wu, F. Y., Ahn, J. H., Alcendor, D. J. et al. (2001). Origin-independent assembly of Kaposi's sarcoma-associated herpesvirus DNA replication compartments in transient cotransfection assays and association with the ORF-K8 protein and cellular PML. J. Virol., 75(3), 1487-1506.
259. Wu, F. Y., Tang, Q. Q., Chen, H. et al. (2002). Lytic replication-associated protein (RAP) encoded by Kaposi sarcoma-associated herpesvirus causes p21CIP-1-mediated G1 cell cycle arrest through CCAAT/enhancer-binding protein-alpha. Proc. Natl Acad. Sci. USA, 99(16), 10683-10688.
260. Wu, F. Y., Wang, S. E., Tang, Q. Q. et al. (2003). Cell cycle arrest by Kaposi's sarcoma-associated herpesvirus replication-associated protein is mediated at both the transcriptional and posttranslational levels by binding to CCAAT/enhancer-binding protein alpha and p21(CIP-1). J. Virol., 77(16), 8893-8914.
261. Wu, L., Lo, P., Yu, X., Stoops, J. K., Forghani, B., and Zhou, Z. H. (2000). Three-dimensionalstructure of the human herpesvirus 8 capsid. J. Virol., 74(20), 9646-9654.
262. Xu, Y., Rodriguez-Huete, A., and Pari, G. S. (2006). Evaluation of lytic origins of replication of Kaposi's Sarcoma-associated Herpesvirus/Human herpesvirus 8 in the context of the viral genome. J. Virol., 80(19), 9905-9909.
263. Yang, C. and Kazanietz, M. G. (2003). Divergence and complexities in DAG signaling: Looking beyond PKC. Trends Pharmacol. Sci., 24(11), 602-608.
264. Yao, L., Salvucci, O., Cardones, A. R. et al. (2003). Selective expres-sion of stromal-derived factor-1 in the capillary vascular endothelium plays a role in Kaposi sarcoma pathogenesis. Blood, 102(12), 3900-3905.
265. Yu, X. K., O'Connor, C. M., Atanasov, I., Damania, B., Kedes, D. H., and Zhou, Z. H. (2003). Three-dimensional structures of the A, B, and C capsids of rhesus monkey rhadinovirus: Insights into gammaherpesvirus capsid assembly, maturation, and DNA packaging. J. Virol., 77(24), 13182-13193.
266. Yu, Y., Wang, S. E., and Hayward, G. S. (2005). The KSHV immediate-early transcription factor RTA encodes ubiquitin E3 ligase activity that targets IRF7 for proteasome-mediated degrada-tion. Immunity, 22, 59-70.
267. Zhong, W., Wang, H., Herndier, B., and Ganem, D. (1996). Restricted expression of Kaposi sarcoma-associated herpesvirus (human herpesvirus 8) genes in Kaposi sarcoma. Proc. Natl Acad. Sci. USA, 93(13), 6641-6646.
268. Zhu, F., Cusano, T., and Yuan, Y. (1999). Identification of the immediate-early transcripts of Kaposi's sarcoma-associated herpesvirus. J. Virol., 73, 5556-5567.
269. Zhu, F. X. and Yuan, Y. (2003). The ORF45 protein of Kaposi's sarcoma-associated herpesvirus is associated with puri?ed virions. J. Virol., 77(7), 4221-4230.
270. Zhu, F. X., King, S. M., Smith, E. J., Levy, D. E., and Yuan, Y. (2002). A Kaposi's sarcoma-associated herpesviral protein inhibits virus-mediated induction of typeI interferon by blocking IRF-7 phosphorylation and nuclear accumulation. Proc. Natl Acad. Sci. USA, 99(8), 5573-5578.
271. Zhu, L., Wang, R., Sweat, A., Goldstein, E., Horvat, R., and Chan-dran, B. (1999b). Comparison of human sera reactivities in immunoblots with recombinant human herpesvirus (HHV)-8 proteins associated with the latent (ORF73) and lytic (ORFs 65, K8.1A, and K8.1B) replicative cycles and in immuno?uo-rescence assays with HHV-8-infected BCBL-1 cells. Virology, 256(2), 381-392.
272. Zhu, F. X., Chong, J. M., Wu, L., and Yuan, Y. (2005). Virionproteinsof Kaposi's sarcoma-associated herpesvirus. J. Virol., 79(2), 800-811.
273. Zoeteweij, J. P., Moses, A. V., Rinderknecht, A. S. et al. (2001). Targeted inhibition of calcineurin signaling blocks calcium-dependent reactivation of Kaposi sarcoma-associated herpesvirus. Blood, 97(8), 2374-2380.